Article
Colistin heteroresistance in Enterobacter due to base heterozygosity at certain phoP and phoQ locations.
Antimicrobial agents and chemotherapy - 5 Nov 2025
Wang Chengcheng, Feng Yu, Zong Zhiyong
Abstract excerpt
Colistin heteroresistance (CHR) is a growing concern in clinical settings. We aimed to investigate CHR for its prevalence in Enterobacter strains, its impact on colistin treatment, and its genetic mechanisms. We analyzed 109 non-duplicated Enterobacter strains isolated from blood cultures. Minimum inhibitory concentrations (MICs) of colistin for each strain were determined using microdilution and CHR was assessed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
